Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Nucleic acid releasing agent and HPV virus nucleic acid detection kit

A nucleic acid release agent, nucleic acid technology, applied in the biological field, can solve the problem of inability to accurately quantify HPV DNA, and achieve the effects of increased experimental cost, high surface tension, and rapid lysis

Pending Publication Date: 2020-05-19
苏州博方生物技术有限公司
View PDF3 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

For example, Chinese patent 201310009055.4 discloses a one-step pathogen nucleic acid fluorescent quantitative PCR detection method, selects a conserved gene sequence for the pathogen nucleic acid to be tested, designs a specific primer probe, uses a nucleic acid rapid release reagent to extract the pathogen nucleic acid, and directly adds the corresponding The PCR reaction solution realizes PCR fluorescence quantitative detection. The invention is simple and fast in operation, has less loss of extracted nucleic acid, and the manufacturing cost of reagents used is low, but its nucleic acid rapid release agent still has an impact on the subsequent PCR amplification detection, and cannot affect serum low Accurate quantification of HPV DNA up to 400 copies / mL

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Nucleic acid releasing agent and HPV virus nucleic acid detection kit
  • Nucleic acid releasing agent and HPV virus nucleic acid detection kit
  • Nucleic acid releasing agent and HPV virus nucleic acid detection kit

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0036] A nucleic acid releasing agent, comprising the composition of 5wt.% Triton X-100 and DCDE, the sodium hydroxide of 50mmol / L, the ethanol of 0.2Vol.%, the sodium dodecylsulfonate of 1wt.%, balance for water. The mass ratio of Tritonx-100 and DCDE is 1:3.

Embodiment 2

[0038]A nucleic acid releasing agent, comprising the composition of 10wt.% Triton X-100 and DCDE, the sodium hydroxide of 100mmol / L, the ethanol of 0.8Vol.%, the sodium dodecylsulfonate of 0.5wt.%, remaining The amount is water. The mass ratio of Tritonx-100 and DCDE is 1:2.

Embodiment 3

[0040] A nucleic acid releasing agent, comprising the composition of 20wt.% Triton X-100 and DCDE, the sodium hydroxide of 200mmol / L, the ethanol of 1Vol.%, the sodium dodecylsulfonate of 0.8wt.%, balance for water. The mass ratio of Tritonx-100 and DCDE is 1:1.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a nucleic acid releasing agent. The nucleic acid releasing agent comprises a composition of Triton X-100 and diethylene glycol monoethyl ether (DCDE) with a mass ratio of 1: (1-3). The low-cost composition of Triton X-100 and DCDE is adopted to replace a traditional guanidine salt and a detergent, and the obtained nucleic acid releasing agent has advantages of safe use, easy degradation, simple operation, and low manufacturing cost, can effectively lyse serum samples containing pathogens, quickly release nucleic acids therein, reduce inhibition of downstream experiments, and has high pathogen lysis efficiency. The invention also discloses an HPV virus nucleic acid detection kit. The kit comprises the nucleic acid releasing agent, is simple and convenient to operate,and high in working efficiency, effectively avoids a link that may occur during the experimental operation, reduces loss of HPV DNA in an extraction process, and has a quantification limit of 45 IU / mL and a detection limit of 22 IU / mL.

Description

technical field [0001] The invention relates to the field of biotechnology, in particular to a nucleic acid release agent and an HPV virus nucleic acid detection kit. Background technique [0002] Real-time fluorescent quantitative PCR detection of free virus in blood is the most advanced clinical detection method at this stage, and it has developed quite maturely, but the extraction steps of viral nucleic acid before detection are very cumbersome, such as: (1) Traditional boiling method: alkali The neutral lysate is directly mixed with the pathogen-containing liquid, lysed at high temperature, and centrifuged to obtain nucleic acid; (2) concentrated boiling method: first use polysaccharide to concentrate and precipitate pathogens, then add alkaline lysate to lyse at high temperature, and centrifuge to obtain nucleic acid; (3) centrifuge Column method: use silica gel membrane or glass fiber membrane to absorb, purify, and elute to obtain nucleic acid; (4) Magnetic bead metho...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12Q1/6806C12Q1/70C12Q1/6851
CPCC12Q1/6806C12Q1/708C12Q1/6851C12Q2600/166C12Q2527/125C12Q2531/113C12Q2545/101
Inventor 王勇潘晓芳邱河
Owner 苏州博方生物技术有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products